AR033871A1 - El uso de espumas polimericas no digerible para secuestrar materiales digeridos con lo cual se inhibe su absorcion por el cuerpo - Google Patents

El uso de espumas polimericas no digerible para secuestrar materiales digeridos con lo cual se inhibe su absorcion por el cuerpo

Info

Publication number
AR033871A1
AR033871A1 ARP020100969A ARP020100969A AR033871A1 AR 033871 A1 AR033871 A1 AR 033871A1 AR P020100969 A ARP020100969 A AR P020100969A AR P020100969 A ARP020100969 A AR P020100969A AR 033871 A1 AR033871 A1 AR 033871A1
Authority
AR
Argentina
Prior art keywords
materials
composition
animal
group
sequestering
Prior art date
Application number
ARP020100969A
Other languages
English (en)
Inventor
Bryn Hird
Ronald James Jandacek
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR033871A1 publication Critical patent/AR033871A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se refiere a composiciones que comprenden una espuma polimérica de celdas abiertas en donde dichas composiciones son útiles para secuestrar materiales lipófilos presentes en el tracto gastrointestinal tales como ácidos grasos, colesterol, y similares, inhibiendo la digestión y/o absorción de tales materiales por el cuerpo. Una composición adecuada para administrar a un animal para el propósito de secuestrar uno o más materiales lipófilos que están presentes en el tracto gastrointestinal, en donde la composición comprende una espuma polimérica de celdas abiertas no digerible, no absorbible. Dicha espuma polimérica comprende un componente que se selecciona del grupo que consiste de celulosas, quitinas, quitosanas, esponjas, acetato de polivinilo y otros de acuerdo con lo descripto en la memoria descriptiva. Un método de secuestrar materiales lipófilos que están presentes en el tracto gastrointestinal de dicho animal y que se selecciona del grupo que consiste de tratar la aflicción gastrointestinal, urgencia fecal, obesidad, hiperlipidemia, diarrea, inhibir el escape anal, reducir niveles de sustancias tóxicas, reducir niveles de colesterol en sangre, inducir saciedad, causar pérdida de peso, causar control de peso, y combinaciones de éstos en un animal. Un kit que comprende (a) una primera composición y una segunda composición que comprende un componente que se selecciona del grupo que consiste de vitaminas, inhibidores de lipasa, laxantes y combinaciones de éstos.
ARP020100969A 2001-03-19 2002-03-19 El uso de espumas polimericas no digerible para secuestrar materiales digeridos con lo cual se inhibe su absorcion por el cuerpo AR033871A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27705801P 2001-03-19 2001-03-19

Publications (1)

Publication Number Publication Date
AR033871A1 true AR033871A1 (es) 2004-01-07

Family

ID=23059227

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100969A AR033871A1 (es) 2001-03-19 2002-03-19 El uso de espumas polimericas no digerible para secuestrar materiales digeridos con lo cual se inhibe su absorcion por el cuerpo

Country Status (14)

Country Link
US (1) US20030072804A1 (es)
EP (1) EP1372673B1 (es)
JP (1) JP4477826B2 (es)
CN (1) CN1296053C (es)
AR (1) AR033871A1 (es)
AT (1) ATE392900T1 (es)
AU (1) AU2002247253B2 (es)
CA (1) CA2437481C (es)
DE (1) DE60226217T2 (es)
ES (1) ES2303545T3 (es)
HK (1) HK1069329A1 (es)
MX (1) MXPA03008499A (es)
MY (1) MY134067A (es)
WO (1) WO2002074343A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
DK1663326T3 (da) * 2003-09-08 2010-06-21 Fmc Biopolymer As Gel-skum baseret på biopolymer
EP1718279A2 (en) * 2004-02-10 2006-11-08 Itzhak Katz Device and method for reducing calorie intake
US20080089933A1 (en) * 2006-10-16 2008-04-17 Amir Alon Device and method for reducing calorie intake
WO2007017842A2 (en) * 2005-08-09 2007-02-15 Tylerton International Inc. Satiety
WO2012061422A2 (en) * 2010-11-02 2012-05-10 The Johns Hopkins University Gastric sponge system and use thereof
US9005635B2 (en) 2011-03-01 2015-04-14 The Procter & Gamble Company Articles and processes for making a porous disintegratable solid substrate for personal health care applications
US8722066B2 (en) * 2011-03-29 2014-05-13 Primigenia, LLC Devices and methods for weight control and weight loss
EP2916913A4 (en) * 2012-03-27 2016-03-02 Primigenia Llc CELLULOSIC SPONGE WITH HIGH POROSITY
JP6230592B2 (ja) * 2012-03-27 2017-11-15 テラテクネ インコーポレイティッド 高多孔性セルローススポンジ
CN104622851B (zh) * 2015-03-13 2017-09-12 山东省药学科学院 一种减肥胶囊及其制备方法
US10799380B2 (en) * 2015-08-20 2020-10-13 The Johns Hopkins University Gastric device and method of use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600186A (en) * 1968-04-23 1971-08-17 Procter & Gamble Low calorie fat-containing food compositions
GB1302548A (es) * 1969-07-28 1973-01-10
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
US3923972A (en) * 1971-10-12 1975-12-02 Monsanto Co Method of lowering blood cholesterol level
US4211765A (en) * 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
US4039489A (en) * 1972-02-22 1977-08-02 Nasa Oil and fat absorbing polymers
FI54811C (fi) * 1972-06-03 1979-03-12 Vega Jose Manuel Regife Foerfarande foer tillvaratagning och rening av zink fraon zinkhaltiga loesningar
US3980968A (en) * 1975-01-02 1976-09-14 Zenith Radio Corporation Non-proportionate AFC system
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
FR2485548A1 (fr) * 1980-06-30 1981-12-31 Lhd Lab Hygiene Dietetique Procede de preparation d'un polymere de structure tridimensionnelle du type polyurethane reticule, produit obtenu selon ce procede et son application en tant qu'agent gonflant, notamment en therapeutique
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
US4401682A (en) * 1981-07-31 1983-08-30 Battista Orlando A Expandable low calorie compositions
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
US6077556A (en) * 1989-04-10 2000-06-20 The Procter & Gamble Company Solid, nondigestible, fat-like compounds
US5603950A (en) * 1990-08-14 1997-02-18 Ratjen; Werner Agent for oral intake
US5260345A (en) * 1991-08-12 1993-11-09 The Procter & Gamble Company Absorbent foam materials for aqueous body fluids and absorbent articles containing such materials
US5268224A (en) * 1991-08-12 1993-12-07 The Procter & Gamble Company Absorbent foam materials for aqueous body fluids and absorbent articles containing such materials
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
SG79904A1 (en) * 1992-10-30 2001-04-17 Procter & Gamble Nondigestible fat compositions containing cocrystallized blend of polyol polyester hardstock and crystal modifier as a passive oil loss control agent
AU682014B2 (en) * 1992-10-30 1997-09-18 Procter & Gamble Company, The Nondigestible fat compositions containing solid polyol polyester polymer for passive oil loss control
US5290820A (en) * 1993-07-29 1994-03-01 Shell Oil Company Process for preparing low density porous crosslinked polymeric materials
US5650222A (en) * 1995-01-10 1997-07-22 The Procter & Gamble Company Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios
US5563179A (en) * 1995-01-10 1996-10-08 The Proctor & Gamble Company Absorbent foams made from high internal phase emulsions useful for acquiring and distributing aqueous fluids
US5750585A (en) * 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6048908A (en) * 1997-06-27 2000-04-11 Biopore Corporation Hydrophilic polymeric material
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
ATE263558T1 (de) * 1998-08-14 2004-04-15 Hoffmann La Roche Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
JP2003508468A (ja) * 1999-09-06 2003-03-04 バイゼル ギュンター 長時間持続性の満腹効果を得るための架橋された薬剤及びその製法
WO2001017510A1 (de) * 1999-09-06 2001-03-15 Beisel Guenther Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung
DE19942365A1 (de) * 1999-09-06 2001-03-15 Guenther Beisel Mittel zur Stimulanz der Darmtätigkeit sowie Verfahren zu dessen Herstellung
US6251421B1 (en) * 2000-09-25 2001-06-26 Sarfaraz K. Niazi Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
DE10062624A1 (de) * 2000-12-15 2002-06-20 Werner Ratjen Oral verabreichbarer Stoff mit schwammartiger Struktur

Also Published As

Publication number Publication date
CN1296053C (zh) 2007-01-24
JP4477826B2 (ja) 2010-06-09
EP1372673A2 (en) 2004-01-02
CA2437481A1 (en) 2002-09-26
DE60226217T2 (de) 2009-05-14
CN1531437A (zh) 2004-09-22
MXPA03008499A (es) 2003-12-08
HK1069329A1 (en) 2005-05-20
AU2002247253B2 (en) 2006-02-02
JP2004526732A (ja) 2004-09-02
MY134067A (en) 2007-11-30
EP1372673B1 (en) 2008-04-23
WO2002074343A2 (en) 2002-09-26
ES2303545T3 (es) 2008-08-16
US20030072804A1 (en) 2003-04-17
WO2002074343A3 (en) 2003-03-13
DE60226217D1 (de) 2008-06-05
CA2437481C (en) 2010-11-02
ATE392900T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
AR033871A1 (es) El uso de espumas polimericas no digerible para secuestrar materiales digeridos con lo cual se inhibe su absorcion por el cuerpo
Mallikarjuna et al. Fournier’s gangrene: current practices
Czarny et al. Toxic effects of single animal hormones and their mixtures on the growth of Chlorella vulgaris and Scenedesmus armatus
MX2013005663A (es) Pelicula de capas multiples biodegradable y desechable con drenaje.
TW200712779A (en) Water mark defect prevention for immersion lithography
Anthis et al. Modular stimuli-responsive hydrogel sealants for early gastrointestinal leak detection and containment
WO2005107773A8 (en) Solid dosage form of wetted heparin
ATE525090T1 (de) Zusammensetzungen, verfahren und sets zur linderung von gastrointestinalen nebenwirkungen von lipase-hemmern
CN107530437A (zh) 止血和伤口愈合剂
Asaolu et al. Ascaris spp
Li et al. Microplastic aging alters the adsorption-desorption behaviors of sulfamethoxazole in marine animals: a study in simulated biological liquids
Thistle Pathophysiology of bile duct stones
EP1645297A3 (en) Biodegradable absorbent material
CN105273209B (zh) 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备
WO2007064800A3 (en) Methods to ameliorate and image angioplasty-induced vascular injury
ES2776637T3 (es) Polímero de alto peso molecular para utilizar
RU2008120343A (ru) Способ получения дезинфицированного органического ила
TW200602285A (en) Lime a cementitious composition and polymer containing settable mixture
WO2010148020A3 (en) Detection of occult blood in feces or urine
RU2006144345A (ru) Способ дифференциальной диагностики алкогольного и неалкогольного стеатогепатита
Aksenova et al. Study of Degradable Polyolefin Compounds
Aysan et al. Experimental adhesion model: effect of viscosities of fluids put in the peritoneal cavity on preventing peritoneal adhesions
Eke Urogenital tract trauma in Port Harcourt
Kavya A Clinical Study of Fournier’s Gangrene and It’s Management
Armstrong Splenectomy and Banti's Disease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal